Flagship explainer
What drives Aquestive Therapeutics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$83.8M | FY2025 |
| |
| Income before tax | −$83.8M | FY2025 |
|
| Operating income | −$71.1M | FY2025 |
|
| $44.5M | FY2025 |
| |
| Ending assets | $160M | FY2025 |
|
| Beginning assets | $101M | FY2024 |
|
| −$33.7M | FY2025 |
| |
| −$60.2M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001398733-26-000018